thexavierlab.bsky.social

thexavierlab.bsky.social

@thexavierlab.bsky.social

Genes to functions. Microbiome in health & disease. Computational biology. Chemical biology. Innate & adaptive immunity. http://broadinstitute.org/xavier-lab https://molbio.massgeneral.org/faculty/343

190 followers30 following87 posts

Applications are open for the Klarman Fellowship at @broadinstitute.org! We are looking for postdoctoral researchers to join the GaMBiT Initiative to develop innovative technologies that translate human genetic discoveries into disease mechanisms, biomarkers, and therapeutic leads.

broadinstitute.orgKlarman FellowshipThe Broad Institute of MIT and Harvard seeks exceptional applicants for the Klarman Fellowship, a postdoctoral research program within the GaMBiT Initiative.

We teamed up with Harri Lahdesmaki at Alto University to develop & validate PepGen, the first fully generative model capable of synthesizing MHCII peptide binders conditioned on allele, partial sequences, & continuous affinity Read the results here: academic.oup.com/bioinformati...

academic.oup.comPepGen: conditional generation of peptides for MHC bindingAbstractMotivation. Peptide-MHC II binding drives adaptive immunity, yet discovery of novel binder peptides remains challenging due to open binding grooves

New work with Ben Medoff's lab, online now! ADAMTS14 regulates YAP-driven fibroblast activation in IPF. We define an ADAMTS14–collagen V–focal adhesion pathway that contributes to $fibrosis, highlighting ADAMTS14 as a potential therapeutic target. doi.org/10.1093/ajrc...

doi.orgADAMTS14 is a Novel Modulator of Fibroblast Mechanoactivation in Pulmonary FibrosisAbstractRationale. Yes-associated protein (YAP)-mediated fibroblast mechanoactivation is an important driver of fibrosis in idiopathic pulmonary fibrosis (

It's that time of year again--we are saying goodbye to more of our youngest and brightest lab members as they transition to the next steps of their careers, either in grad school or in other institutions. This week, we are saying goodbye to Anna, Regan, and Tanvi.

thexavierlab.bsky.social reposted

thexavierlab.bsky.social reposted

Check out this great write-up of a recent study between the @broadinstitute.org , University of Helsinki, and other institutions which has found more than 400 genetic markers that are linked to autoimmune hypothyroidism (AIHT). (1/4) www.broadinstitute.org/news/study-r...

broadinstitute.orgStudy reveals genetic balancing act between autoimmunity and cancer riskResearchers pinpoint genetic factors linked to both higher risk of a common autoimmune disorder and lower cancer risk

By performing a genome-wide association analysis of over 81,000 people with #AIHT in the FinnGen cohort and UK Biobank, the team was also able to distinguish genetic factors related specifically to thyroid biology from those linked to more general autoimmune processes. (2/4)

For an in-depth walkthrough, check out this Tweetorial by first author @00kumar.bsky.social bsky.app/profile/00ku...

Kumar Thurimella, PhD@00kumar.bsky.social

1/ Our paper is out today in @cp-cellsystems.bsky.social. We used protein language models and deep learning to identify candidate protease allergens in the human microbiome. www.cell.com/cell-systems...

These studies firmly establish a foundation for development of an inhibitor of CARD9 inflammatory response. More broadly, this approach illustrates a strategy for using human genetics and chemical biology to guide small-molecule discovery against challenging immune targets. (7/7)

Using time-resolved FRET (TR-FRET) displacement screens, surface plasmon resonance (SPR), and structure-activity relationship studies we identified a benzodiazepine compound with selective CARD9 binding and cellular activity. (5/7)

The optimized compound blocked CARD9-dependent NFκB activation and cytokine release in human dendritic cells and reduced inflammation in mouse model of fungal infection expressing humanized CARD9 (hCARD9), demonstrating the feasibility of pharmacological targeting of CARD9. (6/7)

To explore pharmacological modulation of CARD9, we took a binder-first strategy: a DNA-encoded library screen and subsequent structural studies revealed a ligandable pocket in the CARD9 coiled-coil domain, guiding subsequent chemical exploration. (4/7)

CARD9 is a key immune adaptor required for immune responses against fungi and bacteria and is implicated in multiple inflammatory diseases. The truncation variant CARD9Δ11 protects against Crohn’s disease, suggesting CARD9 inhibition as a strategy for therapeutic intervention. (2/7)

thexavierlab.bsky.social reposted

Fun collaboration with @thexavierlab.bsky.social and Ribbeck groups to figure out how this human lectin plays multiple roles in controlling the #microbiome: stabilizing the mucus barrier and reducing bacteria that breach it. news.mit.edu/2026/protein... #glycotime

news.mit.eduA protein found in the GI tract can neutralize many bacteriaMIT researchers found that a protein called intelectin-2 has broad spectrum antimicrobial activity against bacteria found in the GI tract. Additionally, intelectin-2 can crosslink molecules that make ...
thexavierlab.bsky.social@thexavierlab.bsky.social

Amazing work–with potential therapeutic implications–by the @laurakiessling.bsky.social group reveals dual actions of interlectin-2 in stabilizing mucosal barriers and targeting bacteria that escape a compromised barrier www.nature.com/articles/s41...